Your Article Summary
See Latest ArticlesBlue light-filtering intraocular lenses: Review of potential benefits and side effects
Journal of Cataract & Refractive Surgery, 06/29/09
Cuthbertson FM et al. - The authors consider the background to the development of these IOLs, the evidence for a reduction in short-wavelength light exposure protecting retinal cells and function, and the possible disadvantages of IOLs resulting from their reduced light transmission. The authors place this information in context with regard to patients having cataract surgery and the day-to-day conditions in which they live.
Related Articles
Primary anterior chamber intraocular lens for the treatment of severe crystalline lens subluxation
Journal of Cataract & Refractive Surgery, 10/15/09
Relevance Score: 93%
Increased Resistance of Contact Lens-Related Bacterial Biofilms to Antimicrobial Activity of Soft Contact Lens Care Solutions
Cornea, 10/13/09
Relevance Score: 93%
Corneal thinning associated with recurrent microbial keratitis resulting from 7-day extended wear of low Dk hydrogel contact lenses
Contact Lens and Anterior Eye, 11/10/09
Relevance Score: 91%
Results of intraocular lens implantation with capsular tension ring in subluxated crystalline or cataractous lenses in children
Indian Journal of Ophthalmology, 11/02/09
Relevance Score: 91%
Hyphal Penetration of Worn Hydrogel Contact Lenses by Fusarium
Cornea, 10/07/09
Relevance Score: 91%
Today in Lens and Cataract...keeping you current
Receive free subspecialty "5-minute updates" via email
Surgical Correction of Presbyopia with Intraocular Lenses Designed to Accommodate
Optometry and Vision Science, 12/04/09
An Outbreak of Early-Onset Endophthalmitis Caused by Fusarium Species following Cataract Surgery
Current Eye Research, 12/03/09
N-Acetylcarnosine Lubricant Eyedrops Possess All-In-One Universal Antioxidant Protective Effects of L-Carnosine in Aqueous and Lipid Membrane Environments, Aldehyde Scavenging, and Transglycation Activities Inherent to Cataracts: A Clinical Study of the New Vision-Saving Drug N-Acetylcarnosine Eyedrop Therapy in a Database Population of Over 50,500 Patients
American Journal of Therapeutics, 12/02/09